The Role of Brain Natriuretic Peptide in the Prediction of Cardiac Performance in Coronary Artery Bypass Grafting

Texas Heart Institute Journal

Volumn 30, Issue 4, 2003, Pages 298-304

  Saribulbul, Osman ^a,d   Alat, Ilker ^b   Coskun, Senol ^a   Apaydin, Anil Z ^c   Yagdi, Tahir ^c   Kiliccioglu, Mefkure ^c   Alayunt, Emin Alp ^c  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c EGE UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass; Natriuretic peptide, brain; Nerve tissue proteins blood; Predictive value of tests; Prospective studies

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; INOTROPIC AGENT; PLASMA PROTEIN;

ADULT; AGED; ANAMNESIS; ARTERY CLAMP; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PERFORMANCE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; MALE; MEASUREMENT; PLASMA; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURGICAL TECHNIQUE;

ADULT; AGED; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; HEART; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0345060324     PISSN: 07302347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Anderson JV, Donckier J, McKenna WJ, Bloom SR. The plasma release of atrial natriuretic peptide in man. Clin Sci (Lond) 1986;71(2):151-5.
2. Yamada H, Saito Y, Mukoyama M, Nakao K, Yasue H, Ban T, et al. Immunohistochemical localization of atrial natriuretic polypeptide (ANP) in human atrial and ventricular myocardiocytes. Histochemistry 1988;89(5):411-3.
3. Berger R, Strecker K, Huelsmann M, Moser P, Frey B, Bojic A, et al. Prognostic power of neurohumoral parameters in chronic heart failure depends on clinical stage and observation period. J Heart Lung Transplant 2003;22(9):1037-45.
4. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988;332:78-81.
5. Wei CM, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CG, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88(3):1004-9.
6. Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet 1993;341(8853):1109-13.
7. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Itoh M, Amaha K. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care 1997;12(2):66-71.
8. Morimoto K, Mori T, Ishiguro S, Matsuda N, Hara Y, Kuroda H. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today 1998;28(1):23-9.
9. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
10. Grantham JA, Borgeson DD, Burnett JC Jr. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol 1997;272(4 Pt 2):R1077-83.
11. Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, et al. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88:372-80.
12. Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Morita E, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991;180:431-6.
13. Lang CC, Coutie WJ, Khong TK, Choy AM, Struthers AD. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens 1991;9:779-82.
14. Itoh H, Sagawa N, Nanno H, Mori T, Mukoyama M, Itoh H, Nakao K. Impaired guanosine 3′,5′-cyclic phosphate production in severe pregnancy-induced hypertension with high plasma levels of atrial and brain natriuretic peptides. Endocr J 1997;44(3):389-93.
15. Steele IC, McDowell G, Moore A, Campbell NP, Shaw C, Buchanan KD, Nicholls DP. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest 1997;27(4):270-6.
16. Lang CC, Contie WJ, Struthers AD, Dhillon DP, Winter JH, Lipworth BJ. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic obstructive pulmonary disease. Clin Sci (Lond) 1992;83:529-33.
17. Lehot JJ, Piriz H, Carry PY, Gauquelin G, Gharib G, Villard J, et al. Influence of cardiac surgery on atrial natriuretic factor. J Cardiothorac Anesth 1989;3(5 Suppl 1):63.
18. Asari H, Kondo H, Ishihara A, Ando K, Marumo F. Extracorporeal circulation influence on plasma atrial natriuretic pepride concentration in cardiac surgery patients. Chest 1989;96(4):757-60.
19. Agnoletti G, Scotti C, Panzali AF, Ceconi C, Curello S, Alfieri O, et al. Plasma levels of atrial natriuretic factor (ANF) and urinary excretion of ANF, arginine vasopressin and catecholamines in children with congenital heart disease: effect of cardiac surgery. Eur J Cardiothorac Surg 1993;7(10):533-9.
20. Hayashida N, Chihara S, Kashikie H, Tayama E, Yokose S, Akasu K, et al. Biological activity of endogenous atrial natriuretic pepride during cardiopulmonary bypass. Artif Organs 2000;24(10):833-8.
21. Roth-Isigkeit A, Dibbelt L, Eichler W, Schumacher J, Schmucker P. Blood levels of atrial natriuretic peptide, endothelin, cortisol and ACTH in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass. J Endocrinol Invest 2001;24(10):777-85.
22. Morimoto A, Nishikimi T, Takaki H, Okano Y, Matsuoka H, Takishita S, et al. Effect of exercise on plasma adrenomedullin and naturiuretic peptide levels in myocardial infarction. Clin Exp Pharmacol Physiol 1997;24(5):315-20.
23. Jensen KT, Carstens J, Ivarsen P, Pederson EB. A new, fast and reliable radioimmunassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57(6):529-40.
24. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score [published erratum appears in JAMA 1992;268(14):1860]. JAMA 1992;267:2344-8.
25. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score [published erratum appears in JAMA 1992;268(14):1860]. JAMA 1992;267:2344-8.
26. Haug C, Metzele A, Kochs M, Hombach V, Grunert A. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol 1993;16(7):553-7.
27. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97(19):1921-9.
28. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135(5 Pt 1):825-32.
29. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9.
30. Nozaki N, Yamaguchi S, Shirakabe M, Nakamura H, Tomoike H. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn Circ J 1997;61(8):657-64.
31. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, Burnett JC Jr. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9.
32. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure [published erratum appears in J Am Coll Cardiol 1989;14:812]. J Am Coll Cardiol 1989;13:1534-9.
33. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure [published erratum appears in J Am Coll Cardiol 1989;14:812]. J Am Coll Cardiol 1989;13:1534-9.
34. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13.
35. Kambayashi Y, Nakao K, Mukoyama M, Saito Y, Ogawa Y, Shiono S, et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 1990;259(2):341-5.
36. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-16.
37. Ikemoto Y, Nogi S, Teraguchi M, Kojima T, Hirata Y, Kobayashi Y. Early changes in plasma brain and atrial natriuretic peptides in premature infants: correlation with pulmonary arterial pressure. Early Hum Dev 1996;46(1-2):55-62.
38. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998;135:21-8.
39. Maki N, Yoshiyama M, Omura T, Yoshimura T, Kawarabayashi T, Sakamoto K, et al. Effect of diltiazem on cardiac function assessed by echocardiography and neurohumoral factors after reperfused myocardial infarction without congestive heart failure. Cardiovasc Drugs Ther 2001;15(6):493-9.
40. Nakamura M, Kawata Y, Yoshida H, Arakawa N, Koeda T, Ichikawa T, et al. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Am Heart J 1992;124:1283-8.
41. Maisel A. BNP-a small peptide promises a big role. Heart Failure Society of America Fifth Annual Meeting. Update on heart failure diagnosis. 2001 September 9-11; Washington, DC.
42. Buhre W, Weyland A, Schorn B, Scholz M, Kazmaier S, Hoeft A, Sonntag H. Changes in central venous pressure and pulmonary capillary wedge pressure do not indicate changes in right and left heart volume in patients undergoing coronary artery bypass surgery. Eur J Anaesthesiol 1999;16(1):11-7.
43. Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND. Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 1993;27:1538-41.
44. Mair P, Mair J, Bleier J, Hormann C, Balogh D, Puschendorf B. Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest. Clin Chim Acta 1997;261(1):57-8.
45. Curello S, Ceconi C, De Giuli F, Cargnoni A, Alfieri O, Pardini A, et al. Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients. Eur J Cardiothorac Surg 1991;5:205-10.
46. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002;105(15):1760-3.
47. Sayama H, Nakamura Y, Saitou N, Doi Y, Matsukura S, Sakurai H, Kinoshita M. Factors that influence the serum of atrial natriuretic peptide and brain natriuretic peptide concentrations-is there a specific marker for senile patients [in Japanese]? Nippon Ronen Igakkai Zasshi 1998;35(11):851-7.
48. Ferreira R, Fraga C, Carrasquedo F, Hourquebie H, Grana D, Milei J. Comparison between warm blood and crystalloid cardioplegia during open heart surgery. Int J Cardiol 2003;90(2-3):253-60.